Is an independent healthcare industry advisor with broad global experience in medical devices and biopharmaceuticals. He has served most recently in executive leadership roles in Gambro, a large European manufacturer of renal therapy products recently acquired by Baxter Healthcare Corporation. Chuck was President of the Healthcare Division of STERIS Corporation, a leading global provider of medical devices in infection prevention and surgical environments. He started his career with Baxter Healthcare Corporation in the Biosciences Division where he held a variety of commercial leadership roles in North America, Europe and Japan. During his career he has launched numerous successful new products and services in the healthcare market by focusing on solutions that improve the efficacy and safety of care, while addressing overall system cost. He is a former member of BioOhio (Board of Trustees and Executive Committee), AdvaMed, American Chamber of Commerce Japan and Plasma Protein Therapeutics Association (Operations Committee). He is a graduate of The Ohio State University.